4//SEC Filing
Bode John B 4
Accession 0001437749-24-017190
CIK 0001434647other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 9:31 PM ET
Size
6.0 KB
Accession
0001437749-24-017190
Insider Transaction Report
Form 4
Bode John B
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-13+39,200→ 39,200 totalExercise: $4.89Exp: 2034-05-12→ Common Stock (39,200 underlying)
Footnotes (3)
- [F1]The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 13, 2024.
- [F2]This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy.
- [F3]One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date.
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001612084
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 9:31 PM ET
- Size
- 6.0 KB